Afore Capital

Afore Capital is a pre‑seed‑only venture firm that backs founders at the “pre‑everything” moment—before traction, revenue, or even a fully formed product. Its core belief is that the DNA of a company is set in the earliest weeks and that founder quality, speed of learning, and product insight matter far more than any early metric. The firm embraces risk, actively looking for what can go right rather than mitigating downside, and moves quickly to make high‑conviction decisions. Afore is sector‑agnostic across software, with depth in SaaS/enterprise, AI/ML, developer tools, fintech, digital health, and consumer applications. Geography is open; companies can be “anywhere in the world.” To expand the pre‑seed aperture, Afore introduced “Pre‑Seed 2.0,” offering flexible checks from $50K up to $2M+ and complementary programs such as Founders‑in‑Residence and Afore Alpha that provide hands‑on product support, office space, and access to a 10,000‑plus user network. The firm typically leads rounds, anchoring up to ~80% of a standard pre‑seed round, and welcomes cold outreach. This combination of founder‑first philosophy, broad software focus, global reach, and intensive post‑investment resources defines its investment thesis.

Afore Capital explicitly optimizes for founder‑market fit and non‑obvious product or distribution insight over early data. They look for authenticity—a credible founder narrative linked to a real problem—maniacal focus, and a unique product or go‑to‑market wedge. Their diligence framework for pre‑seed evaluates the founder’s “lightning in a bottle” thesis, the steepness of the learning loop, and early design‑partner feedback rather than traditional KPIs. Deal‑makers are attracted by a strong founder narrative, non‑obvious insight, rapid iteration velocity, and early design‑partner engagement. Deal‑breakers include lack of authentic insight, slow iteration, over‑reliance on vanity signals, and chasing hot sectors without genuine founder conviction. The firm emphasizes asking “what can go right,” maintaining an all‑in partner stance to help founders move from zero to traction.

• Modern Health
  B2B mental‑health platform that matches Afore’s focus on early‑stage software solving large enterprise problems.
• Hightouch
  Data‑driven marketing infrastructure aligns with Afore’s thesis on AI‑enabled SaaS and developer‑first tools.
• Neo Financial
  Fintech platform in Canada exemplifies Afore’s interest in non‑US, early‑stage financial services software.
• Gamma
  AI‑native presentation product fits Afore’s early‑stage AI and productivity tooling focus.
• Goldcast
  B2B event‑marketing SaaS aligns with Afore’s enterprise software thesis; Afore participated as a seed investor.
• Inngest
  Developer workflow/infrastructure platform matches Afore’s dev‑tools and infrastructure focus.
• Terminal 49Lead
  Logistics SaaS with a clear product‑first story; Afore’s portfolio tags it as "AFORE PRE-SEED", indicating a lead role.
• New Lantern
  AI‑powered radiology workflow tool fits the firm’s AI‑driven health‑tech thesis.
• Osana Salud
  Digital primary‑care infrastructure for LatAm reflects Afore’s generalist software thesis with geographic insight.

No catalog overlap found yet. Co-investors are derived from each firm's notable investments — connections may surface as more firms are added.